Primary cutaneous B cell lymphoma during methotrexate therapy for rheumatoid arthritis

Journal of Rheumatology

Volumn 27, Issue 6, 2000, Pages 1546-1549

  Fam, Adel G ^a,b   Perez Ordonez, Bayardo ^a   Imrie, Kevin ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b Division of Rheumatology   (Canada)

Author keywords

Methotrexate; Primary cutaneous lymphoma; Rheumatoid arthritis

Indexed keywords

AUROTHIOMALATE; CHLOROQUINE; METHOTREXATE; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLAMINE; PREDNISONE;

ADULT; ARTICLE; B CELL LYMPHOMA; CASE REPORT; DRUG WITHDRAWAL; FEMALE; HUMAN; HUMAN TISSUE; LYMPHOPROLIFERATIVE DISEASE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SKIN LYMPHOMA; TUMOR REGRESSION;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; FEMALE; HUMANS; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL; METHOTREXATE; MIDDLE AGED; SKIN NEOPLASMS;

EID: 0034121628     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Gridley G, McLaughlin JK, Ekbom A, et al. Incidence of cancer among patients with rheumatoid arthritis. J Nat Cancer Inst 1993;85:307-11.
2. Moder KG, Tefferi A, Cohen MD, Menke DM, Luthra HS. Hematologic malignancies and the use of methotrexate in rheumatoid arthritis: a retrospective study. Am J Med 1995;99:276-81.
3. Georgescu L, Quinn GC, Schwartzman S, Paget SA. Lymphoma in patients with rheumatoid arthritis: association with the disease state or methotrexate treatment. Semin Arthritis Rheum 1997;29:794-804.
4. Wolfe F. Inflammatory activity, but not methotrexate or prednisone uses predicts non-Hodgkin's lymphoma in rheumatoid arthritis: a 25-year study of 1,767 RA patients [abstract]. Arthritis Rheum 1998;41 Suppl:S188.
5. Kassan SS, Thomas TL, Moutsopoulos HM, et al. Increased risk of lymphoma in sicca syndrome. Ann Intern Med 1978;89:888-92.
6. Gridley G, Klippel JH, Hoover RN, Fraumeni JF. Incidence of cancer among men with Felty's syndrome. Ann Intern Med 1994;120:35-9.
7. Kamel OW, Van de Rijn M, LeBrun DP, Weiss LM, Warnke RA, Dorfman RF. Lymphoid neoplasms in patients with rheumatoid arthritis, and dermatomyositis: frequency of Epstein-Barr virus and other features associated with immunosuppression. Hum Pathol 1994;25:638-43.
8. Bachman TR, Sawitzke AD, Perkins SL, Ward JH, Cannon GW. Methotrexate-associated lymphoma in patients with rheumatoid arthritis. Report of two cases. Arthritis Rheum 1996;39:325-9.
9. Salloum E, Cooper DL, Howe G, et al. Spontaneous regression of lymphoproliferative disorders in patients treated with methotrexate for rheumatoid arthritis and other rheumatic diseases. J Clin Oncol 1996;14:1943-9.
10. Bleyer WA. Methotrexate induced lymphoma [editorial]. J Rheumatol 1998;25:404-7.
11. Chang KL, Chen Y-Y, Shibata D, Weiss LM. Description of in situ hybridization methodology for detection of Epstein-Barr virus RNA in paraffin-embedded tissues, with a survey of normal and neoplastic tissues. Diagn Mol Pathol 1992;1:246-55.
12. Reed TJ, Reid A, Wallberg K, O'Leary TJ, Fizzera G. Determination of B-cell clonality in paraffin-embedded lymph nodes using the polymerase chain reaction. Diagn Mol Pathol 1993;2:42-9.
13. Willemze R, Kerl H, Sterry W, et al. EORTC classification for primary cutaneous lymphomas: a proposal from the cutaneous lymphoma study group of the European Organization for Research and Treatment of Cancer. Blood 1997;90:354-71.
14. Cerroni L, Volkenandt M, Rieger E, Soyer HP, Kerl H. bcl-2 protein expression and correlation with the interchromosomal 14;18 translocation in cutaneous lymphomas and pseudolymphomas. J Invest Dermatol 1994;102:231-5.
15. Morrison VA, Dunn DL, Manivel JC, Gajl-Peczalska KL, Peterson BA. Clinical characteristics of post-transplant lymphoproliferative disorders. Am J Med 1994;97:14-24.
16. Hamilton-Dutoit SJ, Pallesen G, Franzmann MB, et al. AIDS-related lymphoma: histopathology, immunophenotype and association with Epstein-Barr virus as demonstrated by in situ nucleic acid hybridization. Am J Pathol 1991;138:149-63.